ADAR1 expression in different cancer cell lines and its change under heat shock

Dominika Adamczak1, Michał Fornalik1, Anna Małkiewicz1

  • 1Department of Biochemistry and Molecular Biology, Poznan University of Medical Sciences, Święcickiego 6 Street, 60-781, Poznań, Poland.

PubMed

Insights

Adenosine deaminase acting on RNA 1 (ADAR1) expression varies in cancer cells. Cellular stress, like heat shock, did not significantly alter ADAR1 levels, suggesting its potential as a cancer therapeutic target.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • Adenosine deaminase acting on RNA 1 (ADAR1) is crucial in malignancy development by altering oncogene expression.
  • ADAR1 exhibits adenosine-to-inosine RNA editing, modulates IFN pathways, and responds to cellular stress.
  • The ADAR1p110 isoform shifts to the cytoplasm under stress, inhibiting RNA degradation and promoting cell survival.

Purpose of the Study:

  • To assess ADAR1 expression across diverse cancer cell lines.
  • To investigate the impact of cellular stress, specifically heat shock, on ADAR1 expression.

Main Methods:

  • Analysis of ADAR1 expression (transcript and protein levels) in various cancer cell lines.
  • Application of heat shock treatment to evaluate cellular stress response.

Main Results:

  • ADAR1 presence and abundance differ significantly among cancer cell lines of various origins.
  • High ADAR1 transcript levels do not always correlate with protein abundance.
  • ADAR1 transcript and protein levels remained stable under heat shock conditions in the examined cell lines.

Conclusions:

  • ADAR1 expression is cell-type specific and not consistently upregulated by heat shock.
  • Further research into ADAR1's role in specific cancers may identify novel therapeutic targets.